CD8A and myositis disease: Gene expression analysis of peripheral blood mononuclear cells was performed before and after nivolumab in one patient who developed MG/myositis/myocarditis, and revealed an increased expression of CD8 and cytolytic activity markers, whereas CD4+ T-cell and T regulatory cell activity seemed suppressed [22].